NASDAQ:PCSA
Processa Pharmaceuticals Inc. Stock News
$2.17
-0.0900 (-3.98%)
At Close: May 03, 2024
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
08:15am, Thursday, 28'th Mar 2024
HANOVER, MD, March 28, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the n
Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting
08:15am, Monday, 25'th Mar 2024
HANOVER, MD, March 25, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the n
Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference
08:15am, Wednesday, 21'st Feb 2024
HANOVER, MD, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the ne
Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference
01:00pm, Wednesday, 14'th Feb 2024
HANOVER, MD, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the ne
Why Is Processa Therapeutics (PCSA) Stock Up 90% Today?
02:40pm, Thursday, 25'th Jan 2024
Clinical-stage pharmaceutical company Processa Therapeutics (NASDAQ: PCSA ) — which specializes in the field of oncology — is skyrocketing on Thursday. PCSA stock is up about 90% as of this writin
What made Processa Pharmaceuticals stock nearly triple on Thursday?
11:29am, Thursday, 25'th Jan 2024
Processa Pharmaceuticals Inc (NASDAQ: PCSA) says it has completed a safety evaluation of its cancer treatment. Its shares rallied well over 150% on Thursday.
Processa Pharmaceuticals to Present at the Biotech Showcase 2024
05:06pm, Tuesday, 02'nd Jan 2024
HANOVER, MD, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the ne
Processa Pharmaceuticals to Present at the MedInvest Oncology Investor Conference
08:15am, Thursday, 30'th Nov 2023
HANOVER, MD, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the ne
Processa Pharmaceuticals to Present at the 20th Orphan Drugs and Rare Diseases Global Congress 2023 Americas
08:15am, Thursday, 09'th Nov 2023
HANOVER, MD, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the ne
Best Penny Stocks Under $1? 4 To Watch This Week
10:32am, Thursday, 19'th Oct 2023
What are the best penny stocks under $1? If you saw this headline, that's probably a question you have heading into the second half of the week.
Processa Pharmaceuticals to Present at the ThinkEquity Conference
01:08pm, Friday, 13'th Oct 2023
HANOVER, MD, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the ne
Processa Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08:15am, Wednesday, 06'th Sep 2023
HANOVER, MD, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the n
Processa Pharmaceuticals to Present at the Sidoti & Co. Micro Cap Virtual Conference
04:15pm, Thursday, 10'th Aug 2023
HANOVER, MD, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company now focused on developing th
Processa Pharmaceuticals to Present PCS12852 Gastroparesis Results at the Digestive Disease Week 2023 Annual Meeting
08:15am, Friday, 28'th Apr 2023
HANOVER, MD, April 28, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company now focused on developing t
Heatwurx Inc. (PCSA) Upgraded to Buy: Here's What You Should Know
01:42pm, Thursday, 06'th Apr 2023
Heatwurx Inc. (PCSA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.